offline
Merck (MRK) Outpaces Stock Market Gains: What You Should Know
...
Heading into today, shares of the pharmaceutical company had gained 5.58% over the past month, outpacing the Medical sector's gain of 3.15% and the S&P 500's gain of 0.89% in that time.
Investors will be hoping for strength from MRK as it approaches its next earnings release, which is expected to be February 1, 2019. In that report, analysts expect MRK to post earnings of $1.04 per share. This would mark year-over-year growth of 6.12%. Our most recent consensus estimate is calling for quarterly revenue of $11.05 billion, up 5.91% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $4.34 per share and revenue of $42.29 billion, which would represent changes of +9.05% and +5.41%, respectively, from the prior year.
...
https://finance.yahoo.com/news/merck-mrk...10192.html
MRK +1% new all time high
...
Heading into today, shares of the pharmaceutical company had gained 5.58% over the past month, outpacing the Medical sector's gain of 3.15% and the S&P 500's gain of 0.89% in that time.
Investors will be hoping for strength from MRK as it approaches its next earnings release, which is expected to be February 1, 2019. In that report, analysts expect MRK to post earnings of $1.04 per share. This would mark year-over-year growth of 6.12%. Our most recent consensus estimate is calling for quarterly revenue of $11.05 billion, up 5.91% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $4.34 per share and revenue of $42.29 billion, which would represent changes of +9.05% and +5.41%, respectively, from the prior year.
...
https://finance.yahoo.com/news/merck-mrk...10192.html
MRK +1% new all time high
__________________
